Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Plunkett Research, Ltd.
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Syngenta AG To Acquire Pasteuria Bioscience

Wednesday, 19 Sep 2012 01:00am EDT 

Syngenta AG announced that it has agreed to acquire Pasteuria Bioscience, Inc., a US-based biotechnology company. Under the terms of the agreement, Syngenta will acquire Pasteuria Bioscience for aggregate payments of $86 million, with additional deferred payments of up to $27 million. The transaction is expected to close in the fourth quarter of 2012. 

Company Quote

-0.32 -0.44%
11 Jul 2014